Clinical Trial Update: Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Abraxane with radiation therapy for stage III non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: University of Rochester | Conditions: Non-small Cell Lung Cancer, Stage III | Phase 2 | Status: WITHDRAWN